Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
npj Breast Cancer, 2021 Metaplastic breast carcinoma (MpBC) is a rare special histologic subtype of breast carcinoma characterized by the presence of squamous and/or mesenchymal differentiation.
Willard Wong +7 more
semanticscholar +1 more source
BMC Research Notes, 2018 Objectives The aim of this study was to determine the frequency of metaplastic breast carcinoma and invasive micropapillary carcinoma in our population and also to compare the clinico-pathologic features of metaplastic breast carcinoma and invasive ...
Atif Ali Hashmi +10 more
doaj +1 more source
Bone in the breast: A case report of a metaplastic breast cancer with osseous differentiation
Radiology Case Reports, 2021 Metaplastic breast carcinoma is an uncommon malignant tumor with various pathologic subtypes. Diagnosis is often challenging due to the wide spectrum of clinical and imaging presentations.
Kyle Luo, BS, Xiaoqin Wang, MD
doaj +1 more source
Metaplastic Carcinoma Breast with Chondroid Differentiation: A Rare Case Report and Review of Literature [PDF]
National Journal of Laboratory Medicine, 2017 Metaplastic carcinoma of the breast is a rare tumour. Though metaplastic carcinoma is by itself a rare entity, however metaplastic carcinoma with chondroid differentiation makes it even rarer. These tumours are ER, PR, HER2 negative (triple negative)
Vishal Dhingra +4 more
doaj +1 more source
Potential novel therapy targets in neuroendocrine carcinomas of the breast [PDF]
, 2018 Neuroendocrine carcinoma (NEC) of the breast is a rare, special type of breast cancer, reportedly constituting 2% to 5% of all breast cancers. Although breast NEC does not have a specific targeted therapy, several new targeted therapies based on specific
Contreras, Elma +7 more
core +2 more sources
Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma
International Journal of Molecular Sciences, 2021 Metaplastic breast carcinoma (MBC) is a heterogeneous group of infrequent triple negative (TN) invasive carcinomas with poor prognosis. MBCs have a different clinical behavior from other types of triple negative breast cancer (TNBC), being more resistant
Silvia González-Martínez +5 more
semanticscholar +1 more source
Clinical outcomes and patterns of care in the treatment of carcinosarcoma of the breast [PDF]
, 2019 Purpose: Carcinosarcoma of the breast is a rare yet highly aggressive tumor accounting for \u3c1% of all breast cancers, for which guidance on optimal management and prognosis are sparse.
Acharya, Sahaja +4 more
core +2 more sources
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. [PDF]
, 2014 Barretts esophagus (BE) involves a metaplastic replacement of native esophageal squamous epithelium (Sq) by columnar-intestinalized mucosa, and it is the main risk factor for Barrett-related adenocarcinoma (BAc).
Baffa, R +17 more
core +4 more sources
Spindle cell carcinoma of the breast managed with neoadjuvant AIM: A case report
Rare Tumors, 2020 Spindle cell carcinoma (SpC), also known as metaplastic carcinoma—spindle cell type, is a subtype of metaplastic carcinoma. Metaplastic carcinomas of the breast are rare but are thought to be more aggressive than invasive ductal carcinomas.
April Choi +6 more
doaj +1 more source
NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations. [PDF]
, 2013 Inactivating germline mutations in the tumor suppressor gene NF2 cause the hereditary syndrome neurofibromatosis 2, which is characterized by the development of neoplasms of the nervous system, most notably bilateral vestibular schwannoma.
Angelo, Laura S +2 more
core +3 more sources